Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-08 | 2023-07-05 | 194054 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-07-05 | 195164 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195557 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-06-19 | 2023-07-05 | 195563 |
TEVA-DILTIAZEM XC | 360MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-20 | 2023-07-05 | 195763 |
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195772 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195867 |
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195882 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195885 |
TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195888 |
TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194180 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-16 | 2023-07-05 | 195139 |
TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195142 |
TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-19 | 2023-07-05 | 195594 |
TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195751 |
TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-20 | 2023-07-05 | 195778 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2022-12-01 | 2023-07-05 | 176767 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-02-02 | 2023-07-05 | 183361 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2023-06-19 | 2023-07-05 | 195410 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195818 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |